Related Experiment Video
Updated: May 1, 2026

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
Multi-drug resistance in cancer chemotherapeutics: mechanisms and lab approaches
Qiong Wu1, Zhiping Yang1, Yongzhan Nie1
1State Key Laboratory of Cancer Biology and Xijing Hospital of Digestive Diseases, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, China.
Abstract:
Multi-drug resistance (MDR) has become the largest obstacle to the success of cancer chemotherapies. The mechanisms of MDR and the approaches to test MDR have been discovered, yet not fully understood. This review covers the in vivo and in vitro approaches for the detection of MDR in the laboratory and the mechanisms of MDR in cancers. This study also envisages the future developments toward the clinical and therapeutic applications of MDR in cancer treatment. Future therapeutics for cancer treatment will likely combine the existing therapies with drugs originated from MDR mechanisms such as anti-cancer stem cell drugs, anti-miRNA drugs or anti-epigenetic drugs. The challenges for the clinical detection of MDR will be to find new biomarkers and to determine new evaluation systems before the drug resistance emerges.
Insights
Multi-drug resistance (MDR) hinders cancer chemotherapy. This review explores MDR detection methods, mechanisms, and future therapeutic strategies combining novel drugs with existing treatments.
Area of Science:
- Oncology
- Pharmacology
- Molecular Biology
Background:
- Multi-drug resistance (MDR) is a significant challenge in cancer chemotherapy.
- Understanding MDR mechanisms and detection methods is crucial for effective treatment.
Purpose of the Study:
- To review in vivo and in vitro approaches for MDR detection.
- To discuss the mechanisms of MDR in cancers.
- To explore future clinical and therapeutic applications of MDR.
Main Methods:
- Literature review of in vivo and in vitro MDR detection methods.
- Analysis of current understanding of MDR mechanisms.
- Exploration of emerging therapeutic strategies targeting MDR.
Main Results:
- MDR mechanisms are complex and not fully understood.
- Various laboratory methods exist for MDR detection.
- Future therapies may involve anti-cancer stem cell, anti-miRNA, and anti-epigenetic drugs.
Conclusions:
- Future cancer treatments will likely integrate MDR-targeted therapies.
- Development of new biomarkers and evaluation systems is essential for early MDR detection.
- Overcoming MDR is key to improving chemotherapy success rates.
More Related Videos
08:59Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
Published on: December 11, 2017
09:58Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models
Published on: December 9, 2016
Related Concept Videos
Treatment Resistant Cancers
Adaptive Mechanisms in Cancer Cells
Treatment Resistent Cancers
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Targeted Cancer Therapies
There are several types of targeted therapies against...